Initiative known internally as Transformer aims to realize Bezos’s vision of a personalized, voice-driven computing assistant ...

Discover AI Productivity Tools Adoption in Software Engineering Statistics with key data, and trends shaping developer ...

According to Sky Germany, RB Leipzig must generate more than €100million in revenue from player transfers again, regardless of achieving Champions League qualification. This, based on the report, is a ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Construction of Hub William apartments underway at 333 East William St. Wednesday evening. Harper King/DAILY. Buy this photo. Washtenaw County Commissioner Yousef Rabhi, D-District 8, visited the site ...

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Text-to-video generating ...

Picture all of Earth’s oceans, which cover about 70% of the planet and are mostly made of hydrogen. Now multiply that by nine. That may be the amount of hydrogen in Earth’s core, possibly making it ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Ares Capital continues to generate core earnings in excess of its hefty dividend. The BDC had a record year for new investments. It's off to a strong start in securing new investments this year. Ares ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...